Titan Biotech schedules 34th AGM for September 29, 2026

1 min read | Published on 03 Sept 2026, 01:24 PM |Updated on 07 Sept 2026, 10:41 AM

Reviewed by

Shriram SScanX News Team

Add as a preferred
source on Google

Key Highlights

Titan Biotech publishes AGM notices in Financial Express and Naya India
34th AGM scheduled for September 29, 2026, via Video Conferencing
E-voting window runs from September 26 to September 28, 2026
Record date for dividend eligibility set for September 22, 2026

*this image is generated using AI for illustrative purposes only.

Titan Biotech has published newspaper advertisements confirming the schedule for its 34th Annual General Meeting (AGM). The company notified the BSE on September 7, 2026, regarding these disclosures.

The advertisements were placed in Financial Express and Naya India on September 6, 2026, in English and Hindi respectively. This step ensures compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

AGM Details

The 34th AGM is scheduled to take place on Tuesday, September 29, 2026, at 3:00 pm. The meeting will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM). Shareholders can access the notice and related information on the company’s website.

E-Voting and Record Date

Shareholders eligible as of the record date can cast their votes remotely. The cut-off date for e-voting eligibility is September 22, 2026. The remote e-voting window opens on September 26, 2026, at 10:00 am and closes on September 28, 2026, at 5:00 pm.

Key Dates

Event	Date	Time
Record Date	September 22, 2026	-
Book Closure Start	September 23, 2026	-
Book Closure End	September 29, 2026	-
AGM Date	September 29, 2026	3:00 pm

Charanjit Singh, Company Secretary and Compliance Officer, confirmed these details in communications to the BSE.

Historical Stock Returns for Titan Biotech

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.42%	-3.89%	+2.44%	-10.14%	+117.16%	+477.17%

What specific financial resolutions or strategic initiatives are expected to be proposed at Titan Biotech's 34th AGM?

How might the adoption of VC/OAVM for the AGM impact shareholder participation rates and voting outcomes compared to previous years?

Are there any pending regulatory inquiries or compliance issues that shareholders may raise during the Q&A session of the virtual meeting?

Titan Biotech

View Company Insights

View All News

Titan Biotech fixes Sep 22 as record date for ₹0.50 final dividend

0 min read | Published on 03 Sept 2026, 12:52 PM |Updated on 03 Sept 2026, 12:52 PM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

Key Highlights

Titan Biotech fixed September 22, 2026, as the record date for the FY26 final dividend
The Board recommended a payout of ₹0.50 per equity share of face value ₹2
The dividend requires approval at the upcoming 34th Annual General Meeting
Payment will follow the AGM, subject to applicable tax deductions

*this image is generated using AI for illustrative purposes only.

Titan Biotech Limited has fixed September 22, 2026, as the record date for determining shareholder eligibility for the final dividend for financial year 2025-26. The Board of Directors had recommended a payout of ₹0.50 per equity share during its meeting on May 30, 2026.

The proposed dividend is subject to approval by shareholders at the company’s 34th Annual General Meeting (AGM). If approved, the payment will be made after the AGM, subject to deduction of tax at source.

Dividend Details

Parameter	Detail
Dividend Amount	₹0.50 per equity share
Face Value	₹2
Record Date	September 22, 2026
Financial Year	FY26
Approval Status	Pending AGM

The intimation was issued pursuant to Regulation 42 of the SEBI Listing Regulations. Shareholders holding equity shares on the record date will be entitled to receive the dividend once ratified by the general body.

Historical Stock Returns for Titan Biotech